The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
The Medicinal Chemistry of Therapeutic Oligonucleotides
Abstract
Oligonucleotide-based therapeutics have made rapid progress in the clinic for treatment of a variety of disease indications. Unmodified oligonucleotides are polyanionic macromolecules with poor drug-like properties. Over the past two decades, medicinal chemists have identified a number of chemical modification and conjugation strategies which can improve the nuclease stability, RNA-binding affinity, and pharmacokinetic properties of oligonucleotides for therapeutic applications. In this perspective, we present a summary of the most commonly used nucleobase, sugar and backbone modification, and conjugation strategies used in oligonucleotide medicinal chemistry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fluorine in medicinal chemistry
Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008) · Chem. Soc. Rev. · doi:10.1039/b610213c · Cited by 7,570
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
The Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide
Nielsen, P. E., Egholm, M., Berg, R. H., & Buchardt, O. (1991) · Science · doi:10.1126/science.1962210 · Cited by 3,332
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules
Egholm, M., Buchardt, O., Christensen, L., Behrens, C., Freier, S. M., Driver, D. A., Berg, R. H., Kim, S. K., Norden, B., & Nielsen, P. E. (1993) · Nature · doi:10.1038/365566a0 · Cited by 2,079
Altona, C., & Sundaralingam, M. (1972) · Journal of the American Chemical Society · doi:10.1021/ja00778a043 · Cited by 2,056
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., & Tuschl, T. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.007 · Cited by 2,052
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity
Song, J.-J., Smith, S. K., Hannon, G. J., & Joshua-Tor, L. (2004) · Science · doi:10.1126/science.1102514 · Cited by 1,470
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141
Morpholino Antisense Oligomers: Design, Preparation, and Properties
SUMMERTON, J., & WELLER, D. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.187 · Cited by 1,116
Koshkin, A. A., Singh, S. K., Nielsen, P., Rajwanshi, V. K., Kumar, R., Meldgaard, M., Olsen, C. E., & Wengel, J. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00094-5 · Cited by 1,047
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971
Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M.-J., Cromwell, W. C., Lachmann, R. H., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 924
Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60756-3 · Cited by 878
Eteplirsen for the treatment of Duchenne muscular dystrophy
Mendell, J. R., Rodino‐Klapac, L. R., Sahenk, Z., Roush, K., Bird, L., Lowes, L. P., Alfano, L., Gomez, A. M., Lewis, S., Kota, J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23982 · Cited by 817
Ribonuclease H: the enzymes in eukaryotes
Cerritelli, S. M., & Crouch, R. J. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.06908.x · Cited by 814
Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., & Freier, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85268-7 · Cited by 778
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Peptide nucleic acids (PNA). Oligonucleotide analogs with an achiral peptide backbone
Egholm, M., Buchardt, O., Nielsen, P. E., & Berg, R. H. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00031a062 · Cited by 738
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733
Obika, S., Nanbu, D., Hari, Y., Andoh, J.-I., Morio, K.-I., Doi, T., & Imanishi, T. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01084-3 · Cited by 700
Freier, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.22.4429 · Cited by 692
Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
Eckstein, F. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2014.0506 · Cited by 684
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 664
Silencing of microRNA families by seed-targeting tiny LNAs
Obad, S., dos Santos, C. O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.786 · Cited by 627
Antisense Research and Applications
Agrawal, S., & Crooke, S. T. (1993) · Medical Entomology and Zoology · Cited by 610
Prakash, T. P., Graham, M. J., Yu, J., Carty, R., Low, A., Chappell, A., Schmidt, K., Zhao, C., Aghajan, M., Murray, H. F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku531 · Cited by 610
Self-citationObika, S., Nanbu, D., Hari, Y., Morio, K.-I., In, Y., Ishida, T., & Imanishi, T. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)10322-7 · Cited by 610
Passini, M. A., Bu, J., Richards, A. M., Kinnecom, C., Sardi, S. P., Stanek, L. M., Hua, Y., Rigo, F., Matson, J., Hung, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001777 · Cited by 547
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.32 · Cited by 541
The asialoglycoprotein receptor: relationships between structure, function, and expression
Stockert, R. J. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.591 · Cited by 520
Alter, J., Lou, F., Rabinowitz, A., Yin, H., Rosenfeld, J., Wilton, S. D., Partridge, T. A., & Lu, Q. L. (2006) · Nature Medicine · doi:10.1038/nm1345 · Cited by 494
Swayze, E. E., Siwkowski, A. M., Wancewicz, E. V., Migawa, M. T., Wyrzykiewicz, T. K., Hung, G., Monia, B. P., & Bennett, A. C. F. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1071 · Cited by 469
Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes
Pieken, W. A., Olsen, D. B., Benseler, F., Aurup, H., & Eckstein, F. (1991) · Science · doi:10.1126/science.1857967 · Cited by 463
Allerson, C. R., Sioufi, N., Jarres, R., Prakash, T. P., Naik, N., Berdeja, A., Wanders, L., Griffey, R. H., Swayze, E. E., & Bhat, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049167j · Cited by 448
Hong, D., Kurzrock, R., Kim, Y., Woessner, R., Younes, A., Nemunaitis, J., Fowler, N., Zhou, T., Schmidt, J., Jo, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5272 · Cited by 445
Kawasaki, A. M., Casper, M. D., Freier, S. M., Lesnik, E. A., Zounes, M. C., Cummins, L. L., Gonzalez, C., & Cook, P. D. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00059a007 · Cited by 438
Improved targeting of miRNA with antisense oligonucleotides
Davis, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl183 · Cited by 422
Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne Pyrimidines
Wagner, R. W., Matteucci, M. D., Lewis, J. G., Gutierrez, A. J., Moulds, C., & Froehler, B. C. (1993) · Science · doi:10.1126/science.7684856 · Cited by 405
Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?
ECKSTEIN, F. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.117 · Cited by 382
The Ashwell receptor mitigates the lethal coagulopathy of sepsis
Grewal, P. K., Uchiyama, S., Ditto, D., Varki, N., Le, D. T., Nizet, V., & Marth, J. D. (2008) · Nature Medicine · doi:10.1038/nm1760 · Cited by 374
Stein, C. A., Hansen, J. B., Lai, J., Wu, S., Voskresenskiy, A., H⊘g, A., Worm, J., Hedtjärn, M., Souleimanian, N., Miller, P., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp841 · Cited by 360
Manoharan, M. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00138-4 · Cited by 348
LNA (Locked Nucleic Acid): An RNA Mimic Forming Exceedingly Stable LNA:LNA Duplexes
Koshkin, A. A., Nielsen, P., Meldgaard, M., Rajwanshi, V. K., Singh, S. K., & Wengel, J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9822862 · Cited by 338
Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding.
Brown, D. A., Kang, S. H., Gryaznov, S. M., DeDionisio, L., Heidenreich, O., Sullivan, S., Xu, X., & Nerenberg, M. I. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47090-1 · Cited by 336
Wengel, J. (1999) · Accounts of Chemical Research · doi:10.1021/ar980051p · Cited by 335
Goyenvalle, A., Griffith, G., Babbs, A., Andaloussi, S. E., Ezzat, K., Avril, A., Dugovic, B., Chaussenot, R., Ferry, A., Voit, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3765 · Cited by 327
Guvakova, M. A., Yakubov, L. A., Vlodavsky, I., Tonkinson, J. L., & Stein, C. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2620 · Cited by 326
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
Beltinger, C., Saragovi, H. U., Smith, R. M., LeSauteur, L., Shah, N., DeDionisio, L., Christensen, L., Raible, A., Jarett, L., & Gewirtz, A. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117860 · Cited by 312
Systemically delivered antisense oligomers upregulate gene expression in mouse tissues
Sazani, P., Gemignani, F., Kang, S.-H., Maier, M. A., Manoharan, M., Persmark, M., Bortner, D., & Kole, R. (2002) · Nature Biotechnology · doi:10.1038/nbt759 · Cited by 301
Antisense oligonucleotide pharmacokinetics and metabolism
Geary, R. S. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902877680 · Cited by 300
Silence from within: Endogenous siRNAs and miRNAs
Sontheimer, E. J., & Carthew, R. W. (2005) · Cell · doi:10.1016/j.cell.2005.06.030 · Cited by 291
Chemical modification: the key to clinical application of RNA interference?
Corey, D. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33483 · Cited by 285
RNA interference using boranophosphate siRNAs: structure-activity relationships
Hall, A. H. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh936 · Cited by 285
Koller, E., Vincent, T. M., Chappell, A., De, S., Manoharan, M., & Bennett, C. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr089 · Cited by 281
Herbert, B.-S., Gellert, G. C., Hochreiter, A., Pongracz, K., Wright, W. E., Zielinska, D., Chin, A. C., Harley, C. B., Shay, J. W., & Gryaznov, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208760 · Cited by 268
Seth, P. P., Siwkowski, A., Allerson, C. R., Vasquez, G., Lee, S., Prakash, T. P., Wancewicz, E. V., Witchell, D., & Swayze, E. E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801294h · Cited by 266
Self-citationSingle-Stranded siRNAs Activate RNAi in Animals
Lima, W. F., Prakash, T. P., Murray, H. M., Kinberger, G. A., Li, W., Chappell, A. E., Li, C. S., Murray, S. F., Gaus, H., Seth, P. P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.014 · Cited by 256
Self-citationØstergaard, M. E., & Hrdlicka, P. J. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15014f · Cited by 256
Straarup, E. M., Fisker, N., Hedtjärn, M., Lindholm, M. W., Rosenbohm, C., Aarup, V., Hansen, H. F., Ørum, H., Hansen, J. B. R., & Koch, T. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq457 · Cited by 249
DNA Analogues: From Supramolecular Principles to Biological Properties
Leumann, C. J. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00348-0 · Cited by 248
Marquez, V. E., Siddiqui, M. A., Ezzitouni, A., Russ, P., Wang, J., Wagner, R. W., & Matteucci, M. D. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960306+ · Cited by 247
Locked Nucleic Acids: Promising Nucleic Acid Analogs for Therapeutic Applications
Veedu, R. N., & Wengel, J. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900343 · Cited by 240
Wu, B., Moulton, H. M., Iversen, P. L., Jiang, J., Li, J., Li, J., Spurney, C. F., Sali, A., Guerron, A. D., Nagaraju, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805676105 · Cited by 236
Ein neuer Zugang zu 2′‐O‐Alkylribonucleosiden und Eigenschaften deren Oligonucleotide
Martin, P. (1995) · Helvetica Chimica Acta · doi:10.1002/hlca.19950780219 · Cited by 234
Moulton, H. M., & Moulton, J. D. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.02.012 · Cited by 229
Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
Crooke, S. T., Graham, M. J., Zuckerman, J. E., Brooks, D., Conklin, B. S., Cummins, L. L., Greig, M. J., Guinosso, C. J., Kornbrust, D., Manoharan, M., et al. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12951-0 · Cited by 227
Nielsen, P. E., Haaima, G., Lohse, A., & Buchardt, O. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199619391 · Cited by 221
The first analogues of LNA (Locked Nucleic Acids): Phosphorothioate-LNA and 2′-thio-LNA
Kumar, R., Singh, S. K., Koshkin, A. A., Rajwanshi, V. K., Meldgaard, M., & Wengel, J. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00366-7 · Cited by 219
Antisense Drug Technology: Principles, Strategies, and Applications
Szymkowski, D. E. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02123-7 · Cited by 218
Burel, S. A., Hart, C. E., Cauntay, P., Hsiao, J., Machemer, T., Katz, M., Watt, A., Bui, H.-H., Younis, H., Sabripour, M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1210 · Cited by 216
Self-citationSeth, P. P., Vasquez, G., Allerson, C. A., Berdeja, A., Gaus, H., Kinberger, G. A., Prakash, T. P., Migawa, M. T., Bhat, B., & Swayze, E. E. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo902560f · Cited by 211
Self-citationPlavec, J., Tong, W., & Chattopadhyaya, J. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00074a046 · Cited by 211
Potent inhibition of microRNA in vivo without degradation
Davis, S., Propp, S., Freier, S. M., Jones, L. E., Serra, M. J., Kinberger, G., Bhat, B., Swayze, E. E., Bennett, C. F., & Esau, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn904 · Cited by 200
In vivo imaging of oligonucleotides with positron emission tomography
Tavitian, B., Terrazzino, S., Kühnast, B., Marzabal, S., Stettler, O., Dollé, F., Deverre, J.-R., Jobert, A., Hinnen, F., Bendriem, B., et al. (1998) · Nature Medicine · doi:10.1038/nm0498-467 · Cited by 200
Unexpected origins of the enhanced pairing affinity of 2′-fluoro-modified RNA
Pallan, P. S., Greene, E. M., Jicman, P. A., Pandey, R. K., Manoharan, M., Rozners, E., & Egli, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1270 · Cited by 199
Structural Studies of LNA:RNA Duplexes by NMR: Conformations and Implications for RNase H Activity
Bondensgaard, K., Petersen, M. Å., Singh, S. K., Rajwanshi, V. K., Kumar, R., Wengel, J., & Jacobsen, J. P. (2000) · Chemistry - A European Journal · Cited by 196
Bramsen, J. B., Pakula, M. M., Hansen, T. B., Bus, C., Langkjær, N., Odadzic, D., Smicius, R., Wengel, S. L., Chattopadhyaya, J., Engels, J. W., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq341 · Cited by 195
Oligonucleotide N3'-->P5' phosphoramidates.
Gryaznov, S. M., Lloyd, D. H., Chen, J.-K., Schultz, R. G., DeDionisio, L., Ratmeyer, L. S., & Wilson, W. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5798 · Cited by 195
Unique Gene‐Silencing and Structural Properties of 2′‐Fluoro‐Modified siRNAs
Manoharan, M., Akinc, A., Pandey, R. K., Qin, J., Hadwiger, P., John, M., Mills, K., Charisse, K., Maier, M. A., Nechev, L., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006519 · Cited by 193
Meade, B. R., Gogoi, K., Hamil, A. S., Palm-Apergi, C., Berg, A. V. D., Hagopian, J. C., Springer, A. D., Eguchi, A., Kacsinta, A. D., Dowdy, C. F., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3078 · Cited by 191
Morita, K., Hasegawa, C., Kaneko, M., Tsutsumi, S., Sone, J., Ishikawa, T., Imanishi, T., & Koizumi, M. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00683-7 · Cited by 188
Liang, X.-H., Sun, H., Shen, W., & Crooke, S. T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv143 · Cited by 182
Akdim, F., Visser, M. E., Tribble, D. L., Baker, B. F., Stroes, E. S. G., Yu, R., Flaim, J. D., Su, J., Stein, E. A., & Kastelein, J. J. P. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.003 · Cited by 179
Crystal structure and improved antisense properties of 2'-O-(2-methoxyethyl)-RNA.
Manoharan, M., Egli, M., Teplova, M., Minasov, G., Tereshko, V. A., Inamati, G. B., & Cook, P. D. (1999) · Nature Structural Biology · doi:10.1038/9304 · Cited by 178
Burdick, A. D., Sciabola, S., Mantena, S. R., Hollingshead, B. D., Stanton, R., Warneke, J. A., Zeng, M., Martsen, E., Medvedev, A., Makarov, S. S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku142 · Cited by 178
Oligodeoxyribonucleotide N3'.fwdarw.P5' Phosphoramidates: synthesis and Hybridization Properties
Gryaznov, S., & Chen, J.-K. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00086a062 · Cited by 176
Chen, P. Y., Weinmann, L., Gaidatzis, D., Pei, Y., Zavolan, M., Tuschl, T., & Meister, G. (2008) · RNA · doi:10.1261/rna.789808 · Cited by 176
Hollow Polymer Shells from Biological Templates: Fabrication and Potential Applications
Donath, E., Moya, S. E., Neu, B., Sukhorukov, G. B., Georgieva, R. T., Voigt, A., Bäumler, H., Kiesewetter, H., & Möhwald, H. (2002) · Chemistry - A European Journal · doi:10.1002/1521-3765(20021202)8:23<5312::aid-chem5312>3.0.co;2-m · Cited by 173
Crooke, S. T., & Geary, R. S. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04469.x · Cited by 171
Miller, C. M., Donner, A. J., Blank, E. E., Egger, A. W., Kellar, B. M., Østergaard, M. E., Seth, P. P., & Harris, E. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw112 · Cited by 171
Self-citationThe asialoglycoprotein receptor clears glycoconjugates terminating with sialic acidα2,6GalNAc
Park, E. I., Mi, Y., Unverzagt, C., Gabius, H.-J., & Baenziger, J. U. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508537102 · Cited by 168
Design, Synthesis, and Properties of 2‘,4‘-BNANC: A Bridged Nucleic Acid Analogue
Abdur Rahman, S. M., Seki, S., Obika, S., Yoshikawa, H., Miyashita, K., & Imanishi, T. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710342q · Cited by 163
Østergaard, M. E., Southwell, A. L., Kordasiewicz, H., Watt, A. T., Skotte, N. H., Doty, C. N., Vaid, K., Villanueva, E. B., Swayze, E. E., Frank Bennett, C., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt725 · Cited by 163
Self-citationLin, K.-Y., Jones, R. J., & Matteucci, M. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00118a026 · Cited by 161
Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide
Abes, S., Turner, J. J., Ivanova, G. D., Owen, D., Williams, D., Arzumanov, A. A., Clair, P., Gait, M. J., & Lebleu, B. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm418 · Cited by 157
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
Krieg, A. Μ. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00147-5 · Cited by 154
Gagnon, K. T., Pendergraff, H. M., Deleavey, G. F., Swayze, E. E., Potier, P., Randolph, J., Roesch, E. B., CHATTOPADHYAYA, J. B., Damha, M. J., Bennett, C. F., et al. (2010) · Biochemistry · doi:10.1021/bi101208k · Cited by 153
Doyle, D. F., Braasch, D. A., Simmons, C. G., Janowski, B. A., & Corey, D. R. (2000) · Biochemistry · doi:10.1021/bi0020630 · Cited by 153
Parmar, R. G., Willoughby, J. L. S., Liu, J., Foster, D. J., Brigham, B., Theile, C. S., Charissé, K., Akinc, A., Guidry, E. N., Pei, Y., et al. (2016) · ChemBioChem · doi:10.1002/cbic.201600130 · Cited by 146
α- l -ribo-Configured Locked Nucleic Acid (α-L-LNA): Synthesis and Properties
Sørensen, M. D., Kværnø, L., Bryld, T., Håkansson, A. E., Verbeure, B., Gaubert, G., Herdewijn, P. A., & Wengel, J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0168763 · Cited by 144
Dande, P., Prakash, T. P., Sioufi, N. B., Gaus, H. J., Jarres, R., Berdeja, A., Swayze, E. E., Griffey, R. H., & Bhat, B. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050822c · Cited by 138
Juliano, R. L., Ming, X., Carver, K. A., & Laing, B. M. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0463 · Cited by 135
Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides.
Geary, R. S., Yu, R. Z., & Levin, A. A. (2001) · PubMed · Cited by 133
DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
Nishina, K., Piao, W., Yoshida‐Tanaka, K., Sujino, Y., Nishina, T., Yamamoto, T., Nitta, K., Yoshioka, K., Kuwahara, H., Yasuhara, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8969 · Cited by 132
Self-citationWan, W. B., Migawa, M. T., Vasquez, G., Murray, H. M., Nichols, J. G., Gaus, H. J., Berdeja, A., Lee, S. S., Hart, C. E., Lima, W. F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1115 · Cited by 132
Self-citationPandey, S., Wheeler, T. M., Justice, S. L., Kim, A., Younis, H. S., Gattis, D., Jauvin, D., Puymirat, J., Swayze, E. E., Freier, S. M., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226969 · Cited by 131
Tarköy, M., Bolli, M. H., Schweizer, W. B., & Leumann, C. J. (1993) · Helvetica Chimica Acta · doi:10.1002/hlca.19930760132 · Cited by 129
Steirer, L. M., Park, E. I., Townsend, R. R., & Baenziger, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808689200 · Cited by 128
Kamola, P. J., Kitson, J., Turner, G., Maratou, K., Eriksson, S., Panjwani, A. A., Warnock, L. C., Douillard‐Guilloux, G., Moores, K., Koppe, E. L., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv857 · Cited by 126
Oka, N., Yamamoto, M., Sato, T., & Wada, T. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805780u · Cited by 123
Amides as a New Type of Backbone Modification in Oligonucleotides
Mesmaeker, A. D., Waldner, A., Lebreton, J., Hoffmann, P., Fritsch, V., Wolf, R. M., & Freier, S. M. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199402261 · Cited by 123
Asymmetric RNA duplexes mediate RNA interference in mammalian cells
Sun, X., Rogoff, H. A., & Li, C. J. (2008) · Nature Biotechnology · doi:10.1038/nbt.1512 · Cited by 123
Oligonucleotide N3'-->P5' phosphoramidates as antisense agents
Gryaznov, S. M. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.8.1508 · Cited by 121
Tarköy, M., Bolli, M. H., & Leumann, C. J. (1994) · Helvetica Chimica Acta · doi:10.1002/hlca.19940770315 · Cited by 116
Efficient and Persistent Splice Switching by Systemically Delivered LNA Oligonucleotides in Mice
Roberts, J., Palma, E., Sazani, P., Ørum, H., Cho, M., & Kole, R. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.017 · Cited by 114
Potent and selective inhibition of gene expression by an antisense heptanucleotide
Wagner, R. W., Matteucci, M. D., Grant, D., Huang, T., & Froehler, B. C. (1996) · Nature Biotechnology · doi:10.1038/nbt0796-840 · Cited by 114
Gutierrez, A. J., Terhorst, T. J., Matteucci, M. D., & Froehler, B. C. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00092a003 · Cited by 112
Chemical Modification Study of Antisense Gapmers
Stanton, R. V., Sciabola, S., Salatto, C. T., Weng, Y., Moshinsky, D., Little, J., Walters, E., Kreeger, J. M., DiMattia, D. A., Chen, T. X., et al. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0366 · Cited by 111
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
Rigo, F., Hua, Y., Chun, S. J., Prakash, T. P., Krainer, A. R., & Bennett, C. F. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.939 · Cited by 111
Assessing unintended hybridization-induced biological effects of oligonucleotides
Lindow, M., Vornlocher, H., Riley, D. E., Kornbrust, D. J., Burchard, J., Whiteley, L. O., Kamens, J., Thompson, J. D., Nochur, S. V., Younis, H. S., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2376 · Cited by 111
Egli, M., Minasov, G., Tereshko, V. A., Pallan, P. S., Teplova, M., Inamati, G. B., Lesnik, E. A., Owens, S. R., Ross, B. S., Prakash, T. P., et al. (2005) · Biochemistry · doi:10.1021/bi050574m · Cited by 109
Ezzat, K., Aoki, Y., Koo, T., McClorey, G., Benner, L., Coenen-Stass, A. M. L., O’Donovan, L., Lehto, T., Garcia-Guerra, A., Nordin, J. Z., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b00490 · Cited by 109
Seth, P. P., Siwkowski, A., Allerson, C. R., Vàsquez, G., Lee, S. S., Prakash, T. P., Kinberger, G. A., Migawa, M. T., Gaus, H. J., Bhat, B., et al. (2008) · Nucleic Acids Symposium Series · doi:10.1093/nass/nrn280 · Cited by 105
Self-citationPhosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo
Faria, M., Spiller, D. G., Dubertret, C., Nelson, J. S., White, M., Scherman, D., Hélène, C., & Giovannangeli, C. (2001) · Nature Biotechnology · doi:10.1038/83489 · Cited by 101
Patra, A., Paolillo, M., Charissé, K., Manoharan, M., Rozners, E., & Egli, M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204946 · Cited by 101
Prakash, T. P., Lima, W. F., Murray, H. M., Li, W., Kinberger, G. A., Chappell, A. E., Gaus, H. J., Seth, P. P., Bhat, B., Crooke, S. T., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv162 · Cited by 99
Self-citationOka, N., Wada, T., & Saigo, K. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034502z · Cited by 98
Jones, R. J., Lin, K. Y., Milligan, J. F., Wadwani, S., & Matteucci, M. D. (1993) · The Journal of Organic Chemistry · doi:10.1021/jo00063a014 · Cited by 96
Murray, S., Ittig, D., Koller, E., Berdeja, A., Chappell, A. E., Prakash, T. P., Norrbom, M., Swayze, E. E., Leumann, C. J., & Seth, P. P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks273 · Cited by 95
Self-citationRNA interference induced by siRNAs modified with 4′‐thioribonucleosides in cultured mammalian cells
Hoshika, S., Minakawa, N., Kamiya, H., Harashima, H., & Matsuda, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.073 · Cited by 94
The impact of alternative splicing in vivo: Mouse models show the way
Möröy, T., & Heyd, F. (2007) · RNA · doi:10.1261/rna.554607 · Cited by 87
An Exocyclic Methylene Group Acts As a Bioisostere of the 2′-Oxygen Atom in LNA
Seth, P. P., Allerson, C. R., Berdeja, A., Siwkowski, A. M., Pallan, P. S., Gaus, H. J., Prakash, T. P., Watt, A. T., Egli, M., & Swayze, E. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105875e · Cited by 86
Self-citationCrystal Structure of Double Helical Hexitol Nucleic Acids
Declercq, R., Aerschot, A. A. V., Read, R. J., Herdewijn, P. A., & Meervelt, L. V. (2002) · Journal of the American Chemical Society · doi:10.1021/ja016570w · Cited by 83
Lima, W. F., Nichols, J. G., Wu, H., Prakash, T. P., Migawa, M. T., Wyrzykiewicz, T. K., Bhat, B., & Crooke, S. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405035200 · Cited by 83
Wang, E. S., Wu, K., Chin, A. C., Chen‐Kiang, S., Pongracz, K., Gryaznov, S. M., & Moore, M. A. S. (2003) · Blood · doi:10.1182/blood-2003-02-0546 · Cited by 83
Antisense Oligonucleotide-Based Therapies for Diseases Caused by pre-mRNA Processing Defects
Rigo, F., Seth, P. P., & Bennett, C. F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_9 · Cited by 80
Self-citationHenry, S. P., Geary, R. S., Yu, R. Z., & Levin, A. A. (2001) · PubMed · Cited by 79
Pallan, P. S., Allerson, C. R., Berdeja, A., Seth, P. P., Swayze, E. E., Prakash, T. P., & Egli, M. (2012) · Chemical Communications · doi:10.1039/c2cc32286b · Cited by 79
Self-citationNulf, C. J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh706 · Cited by 78
Burel, S. A., Han, S.-R., Lee, H.-S., Norris, D. A., Lee, B., Machemer, T., Park, S., Zhou, T., He, G., Kim, Y., et al. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0422 · Cited by 77
Yamamoto, T., Harada‐Shiba, M., Nakatani, M., Wada, S., Yasuhara, H., Narukawa, K., Sasaki, K., Shibata, M., Torigoe, H., Yamaoka, T., et al. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.16 · Cited by 74
Srivastava, P., Barman, J., Pathmasiri, W., Plashkevych, O., Wenska, M., & CHATTOPADHYAYA, J. B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja071106y · Cited by 74
Reynolds, M. A., Hogrefe, R. I., Jaeger, J. A., Schwartz, D. A., RILEY, T. A., Marvin, W. B., Daily, W. J., Vaghefi, M. M., Beck, T., Knowles, S. K., et al. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.22.4584 · Cited by 74
Yahara, A., Shrestha, A. R., Yamamoto, T., Hari, Y., Ōsawa, T., Yamaguchi, M., Nishida, M., Kodama, T., & Obika, S. (2012) · ChemBioChem · doi:10.1002/cbic.201200506 · Cited by 73
Flanigan, K. M., Voït, T., Rosales, X. Q., et al. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.09.004 · Cited by 73
Egli, M., Pallan, P. S., Allerson, C. R., Prakash, T. P., Berdeja, A., Yu, J., Lee, S. S., Watt, A. T., Gaus, H. J., Bhat, B., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207086x · Cited by 72
Self-citationSynthesis and properties of 2′-O,4′-C-methyleneoxymethylene bridged nucleic acid
Hari, Y., Obika, S., Ohnishi, R., Eguchi, K., Osaki, T., Ohishi, H., & Imanishi, T. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.09.020 · Cited by 72
Mutisya, D., Selvam, C., Lunstad, B. D., Pallan, P. S., Haas, A., Leake, D., Egli, M., & Rozners, E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku235 · Cited by 71
Yanai, H., Chiba, S., Ban, T., Nakaima, Y., Onoe, T., Honda, K., Ohdan, H., & Taniguchi, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108535108 · Cited by 62
Pedersen, L., Hagedorn, P., Lindholm, M., & Lindow, M. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.72 · Cited by 60
Kakiuchi-Kiyota, S., Koza‐Taylor, P., Mantena, S. R., Nelms, L. F., EnayetAllah, A. E., Hollingshead, B. D., Burdick, A. D., Reed, L. A., Warneke, J. A., Whiteley, L. O., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft278 · Cited by 58
Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts
Ozawa, T., Gryaznov, S. M., Hu, L. J., Pongracz, K., Santos, R. A., Bollen, A. W., Lamborn, K. R., & Deen, D. F. (2004) · Neuro-Oncology · doi:10.1215/s1152851704000055 · Cited by 56
Shrestha, A. R., Kotobuki, Y., Hari, Y., & Obika, S. (2013) · Chemical Communications · doi:10.1039/c3cc46017g · Cited by 55
Wagenaar, T. R., Tolstykh, T., Shi, C., Jiang, L., Zhang, J., Li, Z., Yu, Q., Qu, H., Sun, F., Cao, H., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1367 · Cited by 55
Prakash, T. P., Kinberger, G. A., Murray, H. M., Chappell, A. E., Riney, S., Graham, M. J., Lima, W. F., Swayze, E. E., & Seth, P. P. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.04.063 · Cited by 55
Self-citationBellon, L., Barascut, J., Maury, G., Divita, G., Goody, R. S., & Imbach, J. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.7.1587 · Cited by 53
Howard, F. B., & Miles, H. T. (1984) · Biochemistry · doi:10.1021/bi00321a068 · Cited by 48
The crystal structure of an ‘All Locked’ nucleic acid duplex
Eichert, A., Behling, K., Betzel, C., Erdmann, V., Fürste, J., & Förster, C. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq505 · Cited by 48
Bicyclo-DNA: a Hoogsteen-selective pairing system
Bolli, M. H., Litten, J. C., ̈tz, R. S., & Leumann, C. J. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90263-x · Cited by 48
Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins
Harris, E. N., Baggenstoss, B. A., & Weigel, P. H. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90717.2008 · Cited by 48
Zhou, C., & CHATTOPADHYAYA, J. B. (2012) · Chemical Reviews · doi:10.1021/cr100306q · Cited by 46
Østergaard, M. E., Kumar, P., Nichols, J. G., Watt, A. T., Sharma, P. K., Nielsen, P., & Seth, P. P. (2015) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0547 · Cited by 42
Self-citationHenry, S. P., Seguin, R. M., Cavagnaro, J. A., Berman, C., Tepper, J., & Kornbrust, D. J. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0593 · Cited by 42
Egli, M. (2012) · Accounts of Chemical Research · doi:10.1021/ar200303k · Cited by 41
Albertshofer, K., Siwkowski, A. M., Wancewicz, E. V., Esau, C., Watanabe, T. A., Nishihara, K. C., Kinberger, G. A., Malik, L., Eldrup, A. B., Manoharan, M., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050490b · Cited by 40
Seth, P., Jazayeri, A., Yu, J., Allerson, C., Bhat, B., & Swayze, E. (2012) · Molecular Therapy: Nucleic Acids · doi:10.1038/mtna.2012.34 · Cited by 40
Self-citationHaeberli, P. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki704 · Cited by 40
Wancewicz, E. V., Maier, M. A., Siwkowski, A. M., Albertshofer, K., Winger, T. M., Berdeja, A., Gaus, H. J., Vickers, T. A., Bennett, C. F., Monia, B. P., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901489k · Cited by 39
Dupouy, C., Tarrat, N., Durrieu, M., Rodriguez, F., Escudier, J., & Vigroux, A. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200504475 · Cited by 39
The Medicinal Chemistry of Oligonucleotides
Swayze, E. E., & Bhat, B. (2007) · CRC Press eBooks · doi:10.1201/9780849387951.ch6 · Cited by 39
Oligonucleotide N3′→P5′ thiophosphoramidates: synthesis and properties
Pongracz, K., & Gryaznov, S. M. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(99)01584-1 · Cited by 37
Seth, P. P., Allerson, C. R., Siwkowski, A. M., Vasquez, G., Berdeja, A., Migawa, M. T., Gaus, H. J., Prakash, T. P., Bhat, B., & Swayze, E. E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101207e · Cited by 36
Self-citationHanessian, S., Schroeder, B. R., Giacometti, R. D., Merner, B. L., Østergaard, M. E., Swayze, E. E., & Seth, P. P. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203680 · Cited by 35
Self-citationAndersen, N. K., Døssing, H., Jensen, F., Vester, B., & Nielsen, P. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo200919y · Cited by 35
Lima, W. F., Wu, H., & Crooke, S. T. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)41168-2 · Cited by 34
Synthesis and Biophysical Properties of C5-Functionalized LNA (Locked Nucleic Acid)
Kumar, P., Østergaard, M. E., Baral, B., Anderson, B. A., Guenther, D. C., Kaura, M., Raible, D. J., Sharma, P. K., & Hrdlicka, P. J. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo500614a · Cited by 33
Obika, S., Hari, Y., Morio, K., & Imanishi, T. (2000) · Tetrahedron Letters · doi:10.1016/s0040-4039(99)01998-x · Cited by 33
Burel, S. A., Machemer, T., Ragone, F. L., Kato, H., Cauntay, P., Greenlee, S., Salim, A., Gaarde, W. A., Hung, G., Peralta, R. Q., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.193789 · Cited by 31
Kakiuchi-Kiyota, S., Whiteley, L. O., Ryan, A. M., & Mathialagan, N. (2015) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0576 · Cited by 30
Leydier, C., Bellon, L., Barascut, J., Morvan, F., Rayner, B., & Imbach, J. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.167 · Cited by 29
Thiviyanathan, V., Vyazovkina, K., Gozansky, E. K., Bichenkova, E. V., Abramova, T. V., Luxon, B. A., Lebedev, A. V., & Gorenstein, D. G. (2001) · Biochemistry · doi:10.1021/bi011551k · Cited by 28
Shen, L., Engelhardt, J. A., Hung, G., Yee, J., Kikkawa, R., Matson, J. E., Tayefeh, B., Machemer, T., Giclas, P. C., & Henry, S. P. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0584 · Cited by 28
Evaluation of Basic Amphipathic Peptides for Cellular Delivery of Antisense Peptide Nucleic Acids
Maier, M. A., Esau, C., Siwkowski, A. M., Wancewicz, E. V., Albertshofer, K., Kinberger, G. A., Kadaba, N. S., Watanabe, T. A., Manoharan, M., Bennett, C. F., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051275y · Cited by 26
Haziri, A., & Leumann, C. J. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo300554w · Cited by 24
Synthesis and properties of a bridged nucleic acid with a perhydro-1,2-oxazin-3-one ring.
Shrestha, A. R., Hari, Y., Yahara, A., Ōsawa, T., & Obika, S. (2011) · Journal of Organic Chemistry · doi:10.1021/jo201597e · Cited by 24
Engineered microRNA therapeutics
Gibson, N. (2014) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2014.302 · Cited by 23
Atomic Glimpses on a Billion-Year-Old Molecular Machine
Westhof, É., & Leontis, N. B. (2000) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(20000502)39:9<1656::aid-anie1656>3.0.co;2-q · Cited by 20
Hanessian, S., Wagger, J., Merner, B. L., Giacometti, R. D., Østergaard, M. E., Swayze, E. E., & Seth, P. P. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo401170y · Cited by 20
Self-citationSynthesis, Duplex Stabilization and Structural Properties of a Fluorinated Carbocyclic LNA Analogue
Seth, P. P., Pallan, P. S., Swayze, E. E., & Egli, M. (2012) · ChemBioChem · doi:10.1002/cbic.201200669 · Cited by 19
Self-citationØstergaard, M. E., Gerland, B., Escudier, J., Swayze, E. E., & Seth, P. P. (2014) · ACS Chemical Biology · doi:10.1021/cb5003027 · Cited by 18
Self-citation
Cited by
The chemical evolution of oligonucleotide therapies of clinical utility
Khvorova, A., & Watts, J. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3765 · Cited by 1,216
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
Antisense technology: an overview and prospectus
Crooke, S. T., Baker, B. F., Crooke, R. M., & Liang, X.-H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00162-z · Cited by 775
RNA-based therapeutics: an overview and prospectus
Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05075-2 · Cited by 623
New Modalities for Challenging Targets in Drug Discovery
Valeur, E., Guéret, S. M., Adihou, H., Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N., & Plowright, A. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611914 · Cited by 382
Metadata
- Authors
- Wan, W. B., & Seth, P. P.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-07-29
- Volume
- 59
- Issue
- 21
- Pages
- 9645-9667
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2481500357
- Cited by
- 429
- References
- 205
- FWCI
- 13.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.